Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Design Consideration01:22

Design Consideration

Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key aspect...
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Corrigendum for: Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population, 106:685-695 (10.1002/bdra.23517).

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Response to Dr. Kirby.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Response to letter to the editor by Wise.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Letter to the editor: Comments on venlafaxine paper by Laurent et al.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Evaluation of the Western Australian Register of Developmental Anomalies: Thirty-five years of surveillance.

Birth defects research. Part A, Clinical and molecular teratology·2016

Related Experiment Video

Updated: May 16, 2026

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

Regarding how safe is "safe"?

Clarke Fraser

    Birth Defects Research. Part A, Clinical and Molecular Teratology
    |November 28, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering
    07:47

    Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering

    Published on: September 16, 2016

    Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
    04:55

    Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

    Published on: November 22, 2016

    Related Experiment Videos

    Last Updated: May 16, 2026

    Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices
    08:53

    Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices

    Published on: October 3, 2016

    Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering
    07:47

    Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering

    Published on: September 16, 2016

    Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
    04:55

    Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

    Published on: November 22, 2016